NAPRT and ovarian carcinoma: On the other hand, Chowdhry and colleagues showed that the inducible depletion of NAPRT caused the regression of OV4 xenografts (PH-amplified ovarian cancer), implying that NAPRT inhibitors might be effective as single agents in similar cancer models that highly depend on the PH pathway to survive [24].